Vision and multiple sclerosis

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 1, 2014, Pages 3-16

  Hickman, Simon J ^a   Raoof, Naz ^a   McLean, Rebecca J ^b   Gottlob, Irene ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Diplopia; Multiple sclerosis; Nystagmus; Optic neuritis; Oscillopsia; Vision

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ACETAZOLAMIDE; BACLOFEN; BETA INTERFERON; BOTULINUM TOXIN; CARBAMAZEPINE; CLONAZEPAM; FINGOLIMOD; GABAPENTIN; GLUCOCORTICOID; MEMANTINE; METHYLPREDNISOLONE; NATALIZUMAB; PLACEBO; PREDNISOLONE;

ABDUCENS NERVE INJURY; BLINDNESS; DIPLOPIA; DISEASE ASSOCIATION; EYE MOVEMENT DISORDER; GAZE PARALYSIS; HUMAN; INTERNUCLEAR OPHTHALMOPLEGIA; MORBIDITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OCULOMOTOR NERVE DISEASE; OPTIC NERVE DISEASE; OPTIC NEURITIS; OSCILLOPSIA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; STEREOSCOPIC VISION; TROCHLEAR NERVE DISEASE; UVEITIS; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VISUAL SYSTEM FUNCTION;

EID: 84884289377     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.04.004     Document Type: Review

References (99)

1. W.E. Adams, J.A. Leavitt, and J.M. Holmes Strabismus surgery for internuclear ophthalmoplegia with exotropia in multiple sclerosis Journal of the American Association for Pediatric Ophthalmology and Strabismus 13 2009 13 15
2. L. Averbuch-Heller, R.J. Tusa, L. Fuhry, K.C. Rottach, G.L. Gauser, and W. Heide A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus Annals of Neurology 41 1997 818 825
3. L.J. Balcer, M.L. Baier, J.A. Cohen, M.F. Kooijmans, A.W. Sandrock, and M.L. Nano-Schiavi Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite Neurology 61 2003 1367 1373
4. F. Bandini, E. Castello, L. Mazzella, G.L. Mancardi, and C. Solaro Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? Journal of Neurology, Neurosurgery and Psychiatry 71 2001 107 110
5. D. Barnes, and W.I. McDonald The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements Journal of Neurology, Neurosurgery and Psychiatry 55 1992 863 868
6. J.J. Barton, and T.A. Cox Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy Journal of Neurology, Neurosurgery and Psychiatry 56 1993 262 267
7. M.D. Becker, A. Heiligenhaus, T. Hudde, B. Storch-Hagenlocher, B. Wildemann, and T. Barisani-Asenbauer Interferon as a treatment for uveitis associated with multiple sclerosis British Journal of Ophthalmology 89 2005 1254 1257
8. R.H.B. Benedict, D. Cookfair, R. Gavett, M. Gunther, F. Munschaeur, and N. Garg Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) Journal of the International Neuropsychological Society 12 2006 549 558
9. V. Biousse, C. Trichet, E. Bloch-Michel, and E. Roullet Multiple sclerosis associated with uveitis in two large clinic-based series Neurology 52 1999 179 181
10. J.M. Bruce, A.S. Bruce, and P.A. Arnett Mild visual acuity disturbances are associated with performance on tests of complex visual attention in MS Journal of the International Neuropsychological Society 13 2007 544 548
11. C. Bunce, and R. Wormald Leading causes of certification for blindness and partial sight in England & Wales BioMed Central Public Health 6 2006 58
12. J. Burman, R. Raininko, and J. Fagius Bilateral and recurrent optic neuritis in multiple sclerosis Acta Neurologica Scandinavica 123 2011 207 210
13. E.C. Campos, S. Bellei, and A.A. de Simone Provocative test for early diagnosis of multiple sclerosis Documenta Ophthalmologica 61 1985 113 118
14. N.D. Chiaravalloti, and J. DeLuca Cognitive impairment in multiple sclerosis The Lancet Neurology 7 2008 1139 1151
15. D.B. Clifford, A. De Luca, D.M. Simpson, G. Arendt, G. Giovannoni, and A. Nath Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: Lessons from 28 cases Lancet Neurology 9 2010 438 446
16. C. Confavreux, and S. Vukusic Natural history of multiple sclerosis: a unifying concept Brain 129 2006 606 616
17. F. Costello, and G.P. Van Stavern Should optical coherence tomography be used to manage patients with multiple sclerosis? Journal of Neuro-Ophthalmology 32 2012 363 371
18. M.B. Davies, R. Williams, N. Haq, L. Pelosi, and C.P. Hawkins MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis Neuroradiology 40 1998 765 770
19. J. Derwenskus, J.C. Rucker, A. Serra, J.S. Stahl, D.L. Downey, and N.L. Adams Abnormal eye movements predict disability in MS: two-year follow-up Annals of the New York Academy of Science 1039 2005 521 523
20. M.J. Donaldson, J.S. Pulido, D.C. Herman, N. Diehl, and D. Hodge Pars planitis: a 20-year study of incidence, clinical features, and outcomes American Journal of Ophthalmology 144 2007 812 817
21. M.J. Doslak, L.F. Dell'Osso, and R.B. Daroff A model of Alexander's law of vestibular nystagmus Biological Cybernetics 34 1979 181 186
22. D.L. Downey, J.S. Stahl, R. Bhidayasiri, J. Derwenskus, N.L. Adams, and R.L. Ruff Saccadic and vestibular abnormalities in multiple sclerosis: sensitive clinical signs of brainstem and cerebellar involvement Annals of the New York Academy of Science 956 2002 438 440
23. T. Engell Neurological disease activity in multiple sclerosis patients with periphlebitis retinae Acta Neurologica Scandinavica 73 1986 168 172
24. J.M. Enoch, E.C. Campos, and H.E. Bedell Visual resolution in a patient exhibiting a visual fatigue or saturation-like effect: probable multiple sclerosis Archives of Ophthalmology 97 1979 76 78
25. M.R. Esfahani, Z.A. Harandi, M. Movasat, M. Nikdel, M. Adelpour, and A. Momeni Memantine for axonal loss of optic neuritis Graefes Archive of Clinical and Experimental Ophthalmology 250 2012 863 869
26. P. Feys, W. Helsen, B. Nuttin, A. Lavrysen, P. Ketelaer, and S. Swinnen Unsteady gaze fixation enhances the severity of MS intention tremor Neurology 70 2008 106 113
27. B. Fontaine, D. Seilhean, A. Tourtah, C. Daumas-Duport, C. Duyckaerts, and N. Benoit Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms Journal of Neurology Neurosurgery and Psychiatry 57 1994 353 359
28. J. Fredericksen, H. Larsson, J. Olesen, and B. Stigsby Evaluation of the visual system in multiple sclerosis. II. Colour vision Acta Neurologica Scandinavica 74 1986 203 209
29. L. Frisén, and W.F. Hoyt Insidious atrophy of retinal nerve fibers in multiple sclerosis: funduscopic identification in patients with and without visual complaints Archives of Ophthalmology 92 1974 91 97
30. L. Frisén, and H.A. Quigley Visual acuity in optic atrophy: a quantitative clinicopathological analysis Graefes Archive of Clinical and Experimental Ophthalmology 222 1984 71 74
31. E.M. Frohman, T.C. Frohman, D.S. Zee, R. McColl, and S. Galetta The neuro-ophthalmology of multiple sclerosis Lancet Neurology 4 2005 111 121
32. K.M. Galetta, and L.J. Balcer Measures of visual pathway structure and function in MS: clinical usefulness and role for MS trials Multiple Sclerosis and Related Disorders 2 2013 172 182
33. A.M. Halliday, W.I. McDonald, and J. Mushin Visual evoked response in diagnosis of multiple sclerosis British Medical Journal 4 1973 661 664
34. A.E. Harding, M.G. Sweeney, D.H. Miller, C.J. Mumford, H. Kellar-Wood, and D. Menard Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation Brain 115 1992 979 989
35. A.C. Harrison, W.J. Becker, and W.K. Stell Colour vision abnormalities in multiple sclerosis Canadian Journal of Neurological Sciences 14 1987 279 285
36. C. Heesen, J. Böhm, C. Reich, J. Kasper, M. Goebel, and S.M. Gold Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable Multiple Sclerosis Journal 14 2008 988 991
37. A.P.D. Henderson, S.A. Anand Trip, P.G. Schlottmann, D.R. Altmann, D.F. Garway-Heath, and G.T. Plant An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography Brain 131 2008 277 287
38. S.J. Hickman Neurological visual field defects Neuro-Ophthalmology 35 2011 242 250
39. S.J. Hickman Optic nerve imaging in multiple sclerosis Journal of Neuroimaging 17 Suppl.1 2007 42S 45S
40. S.J. Hickman, C.M. Dalton, D.H. Miller, and G.T. Plant Management of acute optic neuritis The Lancet 360 2002 1953 1962
41. S.J. Hickman, M. Ko, F. Chaudhry, W.M. Jay, and G.T. Plant Optic neuritis: an update typical and atypical optic neuritis Neuro-Ophthalmology 32 2008 237 248
42. R.S.L. Hornabrook, D.H. Miller, M.R. Newton, D.G. MacManus, G.H. du Boulay, and A.M. Halliday Frequent involvement of the optic radiations in patients with acute isolated optic neuritis Neurology 42 1992 77 79
43. L. Horton, A. Conger, D. Conger, G. Remington, T. Frohman, and E. Frohman Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy Neurology 80 2013 1 5
44. N. Jain, and M.T. Bhatti Fingolimod-associated macular edema: incidence, detection, and management Neurology 78 2012 672 680
45. S. Jain, F. Proudlock, C.S. Constantinescu, and I. Gottlob Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis American Journal of Ophthalmology 134 2002 780 782
46. P.F. Jenkins The multiple facets of multiple sclerosis The American Orthoptic Journal 57 2007 69 78
47. J.L. Keltner, C.A. Johnson, J.O. Spurr, R.W. Beck Optic Neuritis Study Group Baseline visual field profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial Archives of Ophthalmology 111 1993 231 234
48. J.F. Kurtzke Clinical manifestations of multiple sclerosis P.J. Vinken, G.W. Bruyen, Handbook of clinical neurology vol. 9 1970 North Holland Publishing Company Amsterdam p. 161-216
49. S. Laatu, A. Revonsuo, P. Hämäläinen, V. Ojanen, and J. Ruutiainen Visual object recognition in multiple sclerosis Journal of the Neurological Sciences 185 2001 77 88
50. M. Langelaan, M.R. de Boer, R.M. van Nispen, B. Wouters, A.C. Moll, and G.H. van Rens Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions Ophthalmic Epidemiology 14 2007 119 126
51. S.J. Leat, G.E. Legge, and M.A. Bullimore What is low vision? A re-evaluation of definitions Optometry and Vision Science 76 1999 198 211
52. J. Le Scanff, P. Sève, C. Renoux, C. Broussolle, C. Confavreux, and S. Vukusic Uveitis associated with multiple sclerosis Multiple Sclerosis Journal 14 2008 415 417
53. J.F. Lovera, E. Frohman, T.R. Brown, D. Bandari, L. Nguyen, and V. Yadav Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial Multiple Sclerosis Journal 16 2010 715 723
54. S.-L. Ma, J.A. Shea, S.L. Galetta, D.A. Jacobs, C.E. Markowitz, and M.G. Maguire Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS- specific vision questionnaire American Journal of Ophthalmology 133 2002 686 692
55. Y. Mao-Draayer, and H. Panitch Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localization Multiple Sclerosis Journal 10 2004 705 707
56. T.H. Margrain Helping blind and partially sighted people to read: the effectiveness of low vision aids British Journal of Ophthalmology 84 2000 919 921
57. R.A. Marrie, G. Cutter, and T. Tyry Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis Multiple Sclerosis Journal 17 2011 1464 1471
58. A.R. Mehta, and C. Kennard The pharmacological treatment of acquired nystagmus Practical Neurology 12 2012 147 153
59. L.R. Mehta, M.P. McDermott, A.D. Goodman, and S.R. Schwid A randomized trial of memantine as treatment for spasticity in multiple sclerosis Multiple Sclerosis Journal 16 2010 248 251
60. A. Meyer-Heim, M. Rothmaier, M. Weder, J. Kool, P. Schenk, and J. Kesselring Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis Multiple Sclerosis Journal 13 2007 232 237
61. A.L. Moura, R.A. Teixeira, N.N. Oiwa, M.F. Costa, C. Feitosa-Santana, and D. Callegaro Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test Visual Neuroscience 25 2008 463 468
62. R. Murthy, E. Dawson, S. Khan, G.G. Adams, and J. Lee Botulinum toxin in the management of internuclear ophthalmoplegia Journal of the American Association for Pediatric Ophthalmology and Strabismus 11 2007 456 459
63. B. Newman Wright, A.J. Wilkins, and Y. Zoukos Spectral filters can improve reading and visual search in patients with multiple sclerosis Journal of Neurology 254 2007 1729 1735
64. NHS National Institute for Health and Clinical Excellence. Clinical Guideline 8: Multiple Sclerosis: Management of multiple sclerosis in primary and secondary care. Issue date: November 2003.
65. Y. Nilsagård, E. Denison, L.G. Gunnarsson, and K. Boström Factors perceived as being related to accidental falls by persons with multiple sclerosis Disability and Rehabilitation 31 2009 1301 1310
66. M. O'Doherty, and D.I. Flitcroft An unusual presentation of optic neuritis and the Pulfrich phenomenon Journal of Neurology, Neurosurgery and Psychiatry 78 2007 906 907
67. Optic Neuritis Study Group Visual function 15 years after optic neuritis: a final follow-up report from the optic neuritis treatment trial Ophthalmology 115 2008 1079 1082
68. I.E.C. Ormerod, D.H. Miller, W.I. McDonald, E.P.G.H. du Boulay, P. Rudge, and B.E. Kendall The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study Brain 110 1987 1579 1616
69. J. Palace Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy Journal of the Neurological Sciences 286 2009 24 27
70. G.T. Plant, A.G. Kermode, G. Turano, I.F. Moseley, D.H. Miller, and D.G. MacManus Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging Neurology 42 1992 68 76
71. C.H. Polman, B.N.J. Uitdehaag, and A.-M. Klok Ocular comorbidity in multiple sclerosis The Lancet 361 2003 1230
72. T. Poyraz, F. Idiman, E. Idiman, S. Özakbas, L. Iyilikçi, and A. Günerli The neuro-ophthalmologic and electrophysiologic evaluation of hypothermia in multiple sclerosis patients with a history of optic neuritis Multiple Sclerosis Journal 16 2010 S270 S271
73. S. Resnikoff, D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, and G.P. Pokharel Global data on visual impairment in the year 2002 Bulletin of the World Health Organization 82 2004 844 851
74. J.P.H. Reulen, E.A.C.M. Sanders, and L.A.H. Hogenhuis Eye movement disorders in multiple sclerosis and optic neuritis Brain 106 1983 121 140
75. Royal National Institute of Blind People. Available from: 〈http://www.rnib.org.uk/livingwithsightloss/ registeringsightloss/pages/registration-benefits.aspxâŒ. [accessed 19.12.12].
76. R. Rudick, J. Antel, C. Confavreux, G. Cutter, G. Ellison, and J. Fischer Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force Annals of Neurology 42 1997 379 382
77. Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA. "Seeing" in NARCOMS: a look at vision- related quality of life in the NARCOMS registry. Multiple Sclerosis Journal, in press.
78. N. Sarvananthan, M. Surendran, E.O. Roberts, S. Jain, S. Thomas, and N. Shah The prevalence of nystagmus: the Leicestershire nystagmus survey Investigative Ophthalmology & Visual Science 50 2009 5201 5206
79. A. Serra, D. Downey, J. Jacobs, M. Walker, and R.J. Leigh Improvement of internuclear ophthalmoparesis in a multiple sclerosis patient taking dalfampridine Neurology 80 2013 P06.015 (Meeting Abstracts 1)
80. M.T. Schultheis, E. Garay, and J. DeLuca Influence of cognitive impairment on driving performance in multiple sclerosis Neurology 56 2001 1089 1094
81. M.T. Schultheis, K. Manning, V. Weisser, A. Blasco, J. Ang, and M.E. Wilkinson Vision and driving in multiple sclerosis Archives of Physical Medicine and Rehabilitation 91 2010 315 317
82. M.T. Schultheis, V. Weisser, J. Ang, E. Elovic, R. Nead, and N. Sestito Examining the relationship between cognition and driving performance in multiple sclerosis Archives of Physical Medicine and Rehabilitation 91 2010 465 473
83. T. Shery, F.A. Proudlock, N. Sarvananthan, R.J. McLean, and I. Gottlob The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study British Journal of Ophthalmology 90 2006 839 843
84. D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Illceto, and C. Sborgia Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity Investigative Ophthalmology & Visual Science 46 2005 1264 1268
85. K.J. Smith, and W.I. McDonald The pathophysiology of multiple sclerosis: the mechanisms underlying The production of symptoms and the natural history of the disease Philosophical Transactions of the Royal Society of London B 354 1999 1649 1673
86. M. Starck, H. Albrecht, W. Pöllmann, M. Dieterich, and A. Straube Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin Journal of Neurology 257 2010 322 327
87. M. Starck, H. Albrecht, W. Pöllmann, M. Dieterich, and A. Straube Drug therapy for acquired pendular nystagmus in multiple sclerosis Journal of Neurology 244 1997 9 16
88. R.J. Swingler, and D.A.S. Compston The morbidity of multiple sclerosis Quarterly Journal of Medicine 83 1992 325 337
89. Y. Tagami, T. Ohnuma, and T. Isayama Visual fatigue phenomenon and prescribing tinted lenses in patients with optic neuritis British Journal of Ophthalmology 68 1984 208 211
90. The Optic Neuritis Study Group Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial American Journal of Ophthalmology 137 2004 77 83
91. M.J. Thurtell, A.C. Joshi, A.C. Leone, R.L. Tomsak, G.S. Kosmorsky, and J.S. Stahl Crossover trial of gabapentin and memantine as treatment for acquired nystagmus Annals of Neurology 67 2010 676 680
92. C. Tilikete, L. Jasse, S. Vukusic, F. Durand-Dubief, C. Vardanian, and D. Pélisson Persistent ocular motor manifestations and related visual consequences in multiple sclerosis J. Rucker, D.S. Zee, Basic and clinical ocular motor and vestibular research vol. 1233 2011 Annals of the New York Academy of Science p. 327-34
93. M.R. Tola, E. Granieri, I. Casetta, P. Monari, R. Scorrano, and V. Mazzeo Retinal periphlebitis in multiple sclerosis: a marker of disease activity? European Neurology 33 1993 93 96
94. A.T. Toosy, S.J. Hickman, K.A. Miszkiel, S.J. Jones, G.T. Plant, and D.R. Altmann Adaptive cortical plasticity in higher visual processing areas after acute optic neuritis Annals of Neurology 57 2005 622 633
95. P. Villoslada, G. Arrondo, J. Sepulcre, M. Alegre, and J. Artieda Memantine induces reversible neurologic impairment in patients with MS Neurology 72 2009 1630 1633
96. L. Vleugels, C. Lafosse, A. van Nunen, S. Nachtergaele, P. Ketelaer, and M. Charlier Visuoperceptual impairment in multiple sclerosis patients diagnosed with neuropsychological tasks Multiple Sclerosis Journal 6 2000 241 254
97. M. Wall, C.A. Johnson, K.E. Kutzko, R. Nguyen, C. Brito, and J.L. Keltner Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects Archives of Ophthalmology 116 1998 53 61
98. M. Wall, and S.H. Wray The one-and-a-half syndrome - a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature Neurology 33 1983 971 980
99. B.D. Youl, G. Turano, D.H. Miller, A.D. Towell, D.G. MacManus, and S.G. Moore The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits Brain 114 1991 2437 2450